Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages

Cellular Immunology

Volumn 313, Issue , 2017, Pages 52-58

  Sommariva, Michele ^a   Le Noci, Valentino ^a   Storti, Chiara ^a   Bianchi, Francesca ^a   Tagliabue, Elda ^b   Balsari, Andrea ^a,b   Sfondrini, Lucia ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Alveolar macrophages; Innate immunity; Lung; NK cells; Toll like receptors

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 33; INTERLEUKIN 6; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; POLYINOSINIC POLYCYTIDYLIC ACID; TLR3 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

ADHERENT CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG METASTASIS; LYMPHOCYTE ACTIVATION; LYMPHOMA CELL LINE; MELANOMA; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; EXPERIMENTAL MELANOMA; HUMAN; IMMUNOLOGY; LUNG TUMOR; METABOLISM; SECONDARY;

ANIMALS; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; POLY I-C; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 9;

EID: 85009469034     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2017.01.004     Document Type: Article

References (24)

1. [1] Moretta, L., Pietra, G., Montaldo, E., Vacca, P., Pende, D., Falco, M., Del, Z.G., Locatelli, F., Moretta, A., Mingari, M.C., Human NK cells: from surface receptors to the therapy of leukemias and solid tumors. Front. Immunol., 5, 2014, 87, 10.3389/fimmu.2014.00087 (eCollection).
2. [2] Chester, C., Fritsch, K., Kohrt, H.E., Natural killer cell immunomodulation: targeting activating, inhibitory, and co-stimulatory receptor signaling for cancer immunotherapy. Front. Immunol., 6, 2015, 601, 10.3389/fimmu.2015.00601 (eCollection).
3. [3] dib-Conquy, M., Scott-Algara, D., Cavaillon, J.M., Souza-Fonseca-Guimaraes, F., TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals. Immunol. Cell Biol. 92 (2014), 256–262.
4. [4] Zhou, Z., Zhang, C., Zhang, J., Tian, Z., Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1. PLoS One, 7, 2012, e36928.
5. [5] Nedvetzki, S., Sowinski, S., Eagle, R.A., Harris, J., Vely, F., Pende, D., Trowsdale, J., Vivier, E., Gordon, S., Davis, D.M., Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109 (2007), 3776–3785.
6. [6] Ebihara, T., Azuma, M., Oshiumi, H., Kasamatsu, J., Iwabuchi, K., Matsumoto, K., Saito, H., Taniguchi, T., Matsumoto, M., Seya, T., Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. J. Exp. Med. 207 (2010), 2675–2687.
7. [7] Girart, M.V., Fuertes, M.B., Domaica, C.I., Rossi, L.E., Zwirner, N.W., Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J. Immunol. 179 (2007), 3472–3479.
8. [8] Mattiola, I., Pesant, M., Tentorio, P.F., Molgora, M., Marcenaro, E., Lugli, E., Locati, M., Mavilio, D., Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1beta, IFN-beta, and IL-15 pathways. J. Immunol. 195 (2015), 2818–2828.
9. [9] Davies, L.C., Jenkins, S.J., Allen, J.E., Taylor, P.R., Tissue-resident macrophages. Nat. Immunol. 14 (2013), 986–995.
10. [10] Hussell, T., Bell, T.J., Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14 (2014), 81–93.
11. [11] Sfondrini, L., Sommariva, M., Tortoreto, M., Meini, A., Piconese, S., Calvaruso, M., Van, R.N., Bonecchi, R., Zaffaroni, N., Colombo, M.P., Tagliabue, E., Balsari, A., Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases. Int. J. Cancer 133 (2013), 383–393, 10.1002/ijc.28028.
12. [12] Le Noci, V., Tortoreto, M., Gulino, A., Storti, C., Bianchi, F., Zaffaroni, N., Tripodo, C., Tagliabue, E., Balsari, A., Sfondrini, L., Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment. OncoImmunology, 4(10), 2015, e1040214, 10.1080/2162402X.2015.1040214.
13. [13] Le Noci, V., Sommariva, M., Tortoreto, M., Zaffaroni, N., Campiglio, M., Tagliabue, E., Balsari, A., Sfondrini, L., Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor. Oncoimmunology, 5(11), 2016, e1234571, 10.1080/2162402X.2016.1234571 (eCollection).
14. [14] Storti, C., Le Noci, V., Sommariva, M., Tagliabue, E., Balsari, A., Sfondrini, L., Aerosol delivery in the treatment of lung cancer. Curr. Cancer Drug Targets 15:7 (2015), 604–612.
15. [15] Tross, D., Petrenko, L., Klaschik, S., Zhu, Q., Klinman, D.M., Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3. Mol. Immunol. 46 (2009), 2557–2564.
16. [16] Bingisser, R.M., Holt, P.G., Immunomodulating mechanisms in the lower respiratory tract: nitric oxide mediated interactions between alveolar macrophages, epithelial cells, and T-cells. Swiss. Med. Wkly. 131 (2001), 171–179.
17. [17] Fernandez, S., Jose, P., Avdiushko, M.G., Kaplan, A.M., Cohen, D.A., Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J. Immunol. 172 (2004), 2613–2620.
18. [18] Baratin, M., Roetynck, S., Lepolard, C., Falk, C., Sawadogo, S., Uematsu, S., Akira, S., Ryffel, B., Tiraby, J.G., Alexopoulou, L., Kirschning, C.J., Gysin, J., Vivier, E., Ugolini, S., Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 14747–14752.
19. [19] Bellora, F., Castriconi, R., Dondero, A., Pessino, A., Nencioni, A., Liggieri, G., Moretta, L., Mantovani, A., Moretta, A., Bottino, C., TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. Eur. J. Immunol. 44 (2014), 1814–1822.
20. [20] Tu, Z., Bozorgzadeh, A., Pierce, R.H., Kurtis, J., Crispe, I.N., Orloff, M.S., TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205 (2008), 233–244.
21. [21] Eissmann, P., Evans, J.H., Mehrabi, M., Rose, E.L., Nedvetzki, S., Davis, D.M., Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J. Immunol. 184 (2010), 6901–6909.
22. [22] Bourgeois, E., Van, L.P., Samson, M., Diem, S., Barra, A., Roga, S., Gombert, J.M., Schneider, E., Dy, M., Gourdy, P., Girard, J.P., Herbelin, A., The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 39 (2009), 1046–1055.
23. [23] Gao, X., Wang, X., Yang, Q., Zhao, X., Wen, W., Li, G., Lu, J., Qin, W., Qi, Y., Xie, F., Jiang, J., Wu, C., Zhang, X., Chen, X., Turnquist, H., Zhu, Y., Lu, B., Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells. J. Immunol. 194 (2015), 438–445.
24. [24] Rezvani, K., Rouce, R.H., The application of natural killer cell immunotherapy for the treatment of cancer. Front. Immunol., 6, 2015, 578, 10.3389/fimmu.2015.00578 (eCollection).